Literature DB >> 23764641

Cross-sectional HIV incidence estimation in HIV prevention research.

Ron Brookmeyer1, Oliver Laeyendecker, Deborah Donnell, Susan H Eshleman.   

Abstract

Accurate methods for estimating HIV incidence from cross-sectional samples would have great utility in prevention research. This report describes recent improvements in cross-sectional methods that significantly improve their accuracy. These improvements are based on the use of multiple biomarkers to identify recent HIV infections. These multiassay algorithms (MAAs) use assays in a hierarchical approach for testing that minimizes the effort and cost of incidence estimation. These MAAs do not require mathematical adjustments for accurate estimation of the incidence rates in study populations in the year before sample collection. MAAs provide a practical, accurate, and cost-effective approach for cross-sectional HIV incidence estimation that can be used for HIV prevention research and global epidemic monitoring.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23764641      PMCID: PMC3737594          DOI: 10.1097/QAI.0b013e3182986fdf

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  41 in total

1.  Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity.

Authors:  Matthew M Cousins; San-San Ou; Maria J Wawer; Supriya Munshaw; David Swan; Craig A Magaret; Caroline E Mullis; David Serwadda; Stephen F Porcella; Ronald H Gray; Thomas C Quinn; Deborah Donnell; Susan H Eshleman; Andrew D Redd
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

2.  Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein.

Authors:  Xierong Wei; Xin Liu; Trudy Dobbs; Debra Kuehl; John N Nkengasong; Dale J Hu; Bharat S Parekh
Journal:  AIDS Res Hum Retroviruses       Date:  2010-01       Impact factor: 2.205

3.  Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.

Authors:  C L Celum; S P Buchbinder; D Donnell; J M Douglas ; K Mayer; B Koblin; M Marmor; S Bozeman; R M Grant; J Flores; H W Sheppard
Journal:  J Infect Dis       Date:  2000-12-08       Impact factor: 5.226

4.  Impact of the Hawthorne effect in a longitudinal clinical study: the case of anesthesia.

Authors:  D De Amici; C Klersy; F Ramajoli; L Brustia; P Politi
Journal:  Control Clin Trials       Date:  2000-04

5.  The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA.

Authors:  Carl A Latkin; Deborah Donnell; David Metzger; Susan Sherman; Apinun Aramrattna; Annet Davis-Vogel; Vu Minh Quan; Sharavi Gandham; Tasanai Vongchak; Tom Perdue; David D Celentano
Journal:  Soc Sci Med       Date:  2008-12-13       Impact factor: 4.634

6.  Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand.

Authors:  Carrie L Young; Dale J Hu; Robert Byers; Suphak Vanichseni; Nancy L Young; Robert Nelson; Philip A Mock; Kachit Choopanya; Robert Janssen; Timothy D Mastro; Joanne V Mei
Journal:  AIDS Res Hum Retroviruses       Date:  2003-06       Impact factor: 2.205

7.  Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand.

Authors:  Gertrude Khumalo-Sakutukwa; Stephen F Morin; Katherine Fritz; Edwin D Charlebois; Heidi van Rooyen; Alfred Chingono; Precious Modiba; Khalifa Mrumbi; Surasing Visrutaratna; Basant Singh; Michael Sweat; David D Celentano; Thomas J Coates
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

8.  HIV incidence determination in the United States: a multiassay approach.

Authors:  Oliver Laeyendecker; Ron Brookmeyer; Matthew M Cousins; Caroline E Mullis; Jacob Konikoff; Deborah Donnell; Connie Celum; Susan P Buchbinder; George R Seage; Gregory D Kirk; Shruti H Mehta; Jacquie Astemborski; Lisa P Jacobson; Joseph B Margolick; Joelle Brown; Thomas C Quinn; Susan H Eshleman
Journal:  J Infect Dis       Date:  2012-11-05       Impact factor: 5.226

9.  Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.

Authors:  Yen T Duong; Maofeng Qiu; Anindya K De; Keisha Jackson; Trudy Dobbs; Andrea A Kim; John N Nkengasong; Bharat S Parekh
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

10.  SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.

Authors:  Leigh Peterson; Kavita Nanda; Baafuor Kofi Opoku; William Kwabena Ampofo; Margaret Owusu-Amoako; Andrew Yiadom Boakye; Wes Rountree; Amanda Troxler; Rosalie Dominik; Ronald Roddy; Laneta Dorflinger
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

View more
  34 in total

1.  A serial risk score approach to disease classification that accounts for accuracy and cost.

Authors:  Dat Huynh; Oliver Laeyendecker; Ron Brookmeyer
Journal:  Biometrics       Date:  2014-08-25       Impact factor: 2.571

2.  Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.

Authors:  Andrew F Longosz; David Serwadda; Fred Nalugoda; Godfrey Kigozi; Veronica Franco; Ronald H Gray; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

3.  HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.

Authors:  Matthew M Cousins; Jacob Konikoff; Oliver Laeyendecker; Connie Celum; Susan P Buchbinder; George R Seage; Gregory D Kirk; Richard D Moore; Shruti H Mehta; Joseph B Margolick; Joelle Brown; Kenneth H Mayer; Beryl A Koblin; Darrell Wheeler; Jessica E Justman; Sally L Hodder; Thomas C Quinn; Ron Brookmeyer; Susan H Eshleman
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

4.  Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

Authors:  Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Hilmarie H Brand; Eric Arts; Immaculate Nankya; Robert A Salata; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-19       Impact factor: 2.205

5.  Brief Report: Impact of Early Antiretroviral Therapy on the Performance of HIV Rapid Tests and HIV Incidence Assays.

Authors:  Jessica M Fogel; Estelle Piwowar-Manning; Barbara Debevec; Tamara Walsky; Katherine Schlusser; Oliver Laeyendecker; Ethan A Wilson; Marybeth McCauley; Theresa Gamble; Gerald Tegha; Dean Soko; Johnstone Kumwenda; Mina C Hosseinipour; Ying Q Chen; Myron S Cohen; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-01       Impact factor: 3.731

6.  Characteristics of patients recently infected with HIV-1 non-B subtypes in France: a nested study within the mandatory notification system for new HIV diagnoses.

Authors:  Denys Brand; Alain Moreau; Françoise Cazein; Florence Lot; Josiane Pillonel; Sylvie Brunet; Damien Thierry; Stéphane Le Vu; Jean-Christophe Plantier; Caroline Semaille; Francis Barin
Journal:  J Clin Microbiol       Date:  2014-09-17       Impact factor: 5.948

Review 7.  CROI 2014: New tools to track the epidemic and prevent HIV infections.

Authors:  Susan P Buchbinder; Albert Y Liu
Journal:  Top Antivir Med       Date:  2014-05

Review 8.  How can we better identify early HIV infections?

Authors:  Nora E Rosenberg; Christopher D Pilcher; Michael P Busch; Myron S Cohen
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

9.  Cross-Sectional HIV Incidence Estimation with Missing Biomarkers.

Authors:  Doug Morrison; Oliver Laeyendecker; Jacob Konikoff; Ron Brookmeyer
Journal:  Stat Commun Infect Dis       Date:  2018-07-31

10.  Segmented polynomials for incidence rate estimation from prevalence data.

Authors:  Severin Guy Mahiané; Oliver Laeyendecker
Journal:  Stat Med       Date:  2016-09-26       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.